- Country: USA
- Summary: Heal Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (Ug3/Uh3 Clinical Trial Optional)
- UST Ref No: 62995817
- Deadline: 23 Feb 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-NS-22-050
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)
CFDA Number : 93.121 -- Oral Diseases and Disorders Research93.213 -- Research and Training in Complementary and Integrative Health93.233 -- National Center on Sleep Disorders Research93.242 -- Mental Health Research Grants93.279 -- Drug Abuse and Addiction Research Programs93.313 -- NIH Office of Research on Women's Health93.393 -- Cancer Cause and Prevention Research93.395 -- Cancer Treatment Research93.837 -- Cardiovascular Diseases Research93.838 -- Lung Diseases Research93.839 -- Blood Diseases and Resources Research93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders93.865 -- Child Health and Human Development Extramural Research93.866 -- Aging Research93.867 -- Vision Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Feb 23, 2023
Posted Date : Feb 08, 2022
Description: The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery of strong candidate biomarkers or biomarker signatures for pain that can be used to facilitate the testing of non-opioid pain therapeutics in Phase II clini... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINHeal Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (Ug3/Uh3 Clinical Trial Optional) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Heal Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (Ug3/Uh3 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 62995817 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-02-23.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
